siRNA therapy decreases triglycerides in patients along with rare disorder
.STUDY FEATURE.19 September 2024.
Plozasiran minimized triglyceride degrees through 80% and lowered the danger of pancreatitis in individuals along with persistent chylomicronemia, along with or even without a genetic prognosis.